RECRUITING

BOLSTER: Learning New Skills to Thrive

Talk to us

Conditions

Gastrointestinal CancerGynecologic CancerAdvanced CancerAdvanced Gastrointestinal CancerAdvanced Gynecologic Cancer

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is evaluating a new program called Building Out Lifelines for Safety, Trust, Empowerment, and Renewal or (BOLSTER), which was designed to support participants with a gynecological or gastrointestinal cancer and new and complex care needs.

Official Title

BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers

Quick Facts

Study Start:2025-05-12
Study Completion:2029-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06936878

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥18 years
  2. * Currently hospitalized with skilled care need or have acquired a new skilled care need as an outpatient
  3. * Diagnosed with advanced gastrointestinal cancer (esophageal, gastric, pancreatic, hepatobiliary, colorectal, unknown GI primary, anal) or advanced gynecologic cancer (ovarian, endometrial, cervical, vaginal, vulvar)
  4. * Has a complex care need (e.g., ostomy, ileostomy, urostomy, nephrostomy, biliary drain, venting gastric tube, feeding tube, intraabdominal or pleural catheter, wound VAC)
  5. * Plans to receive ongoing cancer treatment
  6. * Has a family caregiver or friend (hereafter designated family caregiver) willing to participate
  7. * Able to speak and read English or Spanish (self-report)
  8. * Are willing to be audio-recorded
  9. * Have the cognitive/physical ability to participate in a 60-minute interview
  1. * Has cognitive impairments (as determined by the patient's oncologist)
  2. * Planning to enroll in hospice
  3. * Unable to complete baseline survey
  4. * Adults unable to consent
  5. * Individuals who are not yet adults (infants, children, teenagers)
  6. * Prisoners

Contacts and Locations

Study Contact

Alexi Wright, MD, MPH
CONTACT
617-632-2334
alexi_wright@dfci.harvard.edu
Irene Wang, MPH
CONTACT
617-582-7238
irene_wang@dfci.harvard.edu

Principal Investigator

Alexi Wright, MD MPH
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
United States
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Alexi Wright, MD MPH, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-12
Study Completion Date2029-09-30

Study Record Updates

Study Start Date2025-05-12
Study Completion Date2029-09-30

Terms related to this study

Keywords Provided by Researchers

  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Advanced Cancer
  • Advanced Gastrointestinal Cancer
  • Advanced Gynecologic Cancer

Additional Relevant MeSH Terms

  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Advanced Cancer